U.S. flag

An official website of the United States government

NM_004974.4(KCNA2):c.929A>G (p.His310Arg) AND Developmental and epileptic encephalopathy, 32

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 9, 2018
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001252957.1

Allele description

NM_004974.4(KCNA2):c.929A>G (p.His310Arg)

Gene:
KCNA2:potassium voltage-gated channel subfamily A member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p13.3
Genomic location:
Preferred name:
NM_004974.4(KCNA2):c.929A>G (p.His310Arg)
HGVS:
  • NC_000001.11:g.110603854T>C
  • NG_027997.2:g.32621A>G
  • NM_001204269.2:c.894+35A>G
  • NM_004974.4:c.929A>GMANE SELECT
  • NP_004965.1:p.His310Arg
  • NC_000001.10:g.111146476T>C
  • NM_004974.3:c.929A>G
  • p.His310Arg
Protein change:
H310R
Links:
dbSNP: rs1649470988
NCBI 1000 Genomes Browser:
rs1649470988
Molecular consequence:
  • NM_001204269.2:c.894+35A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004974.4:c.929A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 32 (DEE32)
Synonyms:
Epileptic encephalopathy, early infantile, 32
Identifiers:
MONDO: MONDO:0014607; MedGen: C4225350; Orphanet: 442835; OMIM: 616366

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001427021Clinical Genomics Program, Stanford Medicine
no assertion criteria provided
Likely pathogenic
(Nov 9, 2018)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Clinical Genomics Program, Stanford Medicine, SCV001427021.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedclinical testingnot provided

Description

The p.His310Arg variant in the KCNA2 gene has previously been reported de novo in an individual with severe intellectual disability, motor delay, absent speech, epilepsy, unclassified autism, pervasive behavioral problems and hypertonia (Leiden Open Variation Database (LOVD); personal communication). The p.His310Arg variant is absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). Although this variant is located in a conserved, functional domain (S4 segment of the voltage sensor domain), it is not located in the N-terminal region of the S4 segment where previously reported variants have clustered. However, the KCNA2 gene has fewer missense variants in the general population than expected and a low rate of missense variation may suggest that this gene is intolerant to missense variation. Computational tools predict that the p.His310Arg variant is deleterious; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.His310Arg variant as likely pathogenic for disease in an autosomal dominant manner [ACMG/AMP guidelines used: PM6, PM2, PP2, PP3].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023